Abbott wraps up patient enrollment in Absorb device studies

04/11/2014 | MassDevice.com (Boston)

Abbott has finished enrolling some 2,800 patients in three clinical trials evaluating its Absorb system, a dissolving, drug-eluting scaffold intended to treat patients with heart vessel blockage. The trials, being conducted in the U.S., Japan and China, are meant to back the company's regulatory approval applications for the device in the three countries.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA